My UM
My UM
Search

INOVOTION visit

-

INOVOTION is a biotech company (spin-off from Grenoble-Alpes University) which developed a unique in vivo technology dedicated to efficacy and toxicity evaluations for oncology and immuno-oncology treatments. 

This unique platform provides early analysis of drug candidates from small molecules to 
biologics, before the classical preclinical stage. By eliminating low-value molecules early, 
INOVOTION accelerates the drug discovery process, increases the R&D productivity, and 
reduces its costs.  

INOVOTION built this xenograft model using chicken embryo because it has tremendous 
benefits: fast, robust, affordable, and predictive. These in vivo assays will save time and give 
a clear competitive advantage to public and private researchers.  

This next generation of in vivo efficacy and toxicity tests covers fours main aspects:  
- Efficacy assays for anti-cancer treatments including antibodies and immune-checkpoints  
- Early Toxicity assays for drug candidates  
- Target Validation in oncology  
- Multi-Cancer Screening to (re)positioning a treatment  

INOVOTION has been invited by prof.dr. Ronit Shiri-Sverdlov as part of the monthly Scientific Meeting with Division II within NUTRIM. 

Relevant links

Website: INOVOTION

Also read

  • Global Privacy Officer Certification (ECPC-G)

    This is a specialised, online, hands-on training focused on privacy risk management on a global scale, enabling participants to acquire the “must know knowledge”, the “do’s and don’ts” and most effective methodology to act as Global Data Protection Officer.
    16 Apr
    2 Dec

  • Sustainability Days 2026

    From April 20 to May 20, Maastricht University will celebrate another edition of Sustainability Days. A month dedicated to ideas, collaboration, and action for a more sustainable future.
    20 Apr
    20 May

  • Biodiversity Challenge

    Find and identify as many species as possible on UM grounds within a short period of time.
    30 Apr
    2 Jul